Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does STIVARGA Cause Palmar-plantar erythrodysaesthesia syndrome? 33 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Palmar-plantar erythrodysaesthesia syndrome have been filed in association with STIVARGA. This represents 13.2% of all adverse event reports for STIVARGA.

33
Reports of Palmar-plantar erythrodysaesthesia syndrome with STIVARGA
13.2%
of all STIVARGA reports
9
Deaths
14
Hospitalizations

How Dangerous Is Palmar-plantar erythrodysaesthesia syndrome From STIVARGA?

Of the 33 reports, 9 (27.3%) resulted in death, 14 (42.4%) required hospitalization, and 3 (9.1%) were considered life-threatening.

Is Palmar-plantar erythrodysaesthesia syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for STIVARGA. However, 33 reports have been filed with the FAERS database.

What Other Side Effects Does STIVARGA Cause?

Fatigue (27) Pyrexia (27) Diarrhoea (24) Decreased appetite (23) Dysphonia (23) Hypertension (18) Vomiting (18) Colon cancer (17) Nausea (16) Hepatic function abnormal (15)

What Other Drugs Cause Palmar-plantar erythrodysaesthesia syndrome?

CAPECITABINE (5,294) CABOZANTINIB S-MALATE (2,706) REGORAFENIB (1,230) LENVATINIB (1,211) BEVACIZUMAB (1,079) SORAFENIB (1,040) OXALIPLATIN (980) SUNITINIB MALATE (929) TRASTUZUMAB (919) FLUOROURACIL (837)

Which STIVARGA Alternatives Have Lower Palmar-plantar erythrodysaesthesia syndrome Risk?

STIVARGA vs STRATTERA STIVARGA vs STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE A STIVARGA vs STREPTOMYCIN STIVARGA vs STREPTOMYCIN\STREPTOMYCIN STIVARGA vs STREPTOZOCIN

Related Pages

STIVARGA Full Profile All Palmar-plantar erythrodysaesthesia syndrome Reports All Drugs Causing Palmar-plantar erythrodysaesthesia syndrome STIVARGA Demographics